BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 11925590)

  • 1. The prognostic significance of clinical and pathological features in hepatocellular carcinoma.
    Qin LX; Tang ZY
    World J Gastroenterol; 2002 Apr; 8(2):193-9. PubMed ID: 11925590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
    Tung-Ping Poon R; Fan ST; Wong J
    Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
    Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
    Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma.
    Cillo U; Vitale A; Navaglia F; Basso D; Montin U; Bassanello M; D'Amico F; Ciarleglio FA; Brolese A; Zanus G; De Pascale V; Plebani M; D'Amico DF
    World J Gastroenterol; 2005 Nov; 11(44):6920-5. PubMed ID: 16437593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
    Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
    Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
    Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
    J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Wang L; Qiu SJ; Ye QH; Fan J
    Surgery; 2014 Sep; 156(3):651-60. PubMed ID: 24998159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of recurrent hepatocellular carcinoma.
    Nishizaki T; Takenaka K; Yanaga K; Soejima Y; Uchiyama H; Kishikawa K; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):508-13. PubMed ID: 9164527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.